Medicinal cannabis has already entered mainstream medicine in some countries. This
systematic review (SR) aimed at evaluating the efficacy, acceptability and safety of cannabis …

Setting. Cannabis preparations have been used as a remedy for thousands of years in
traditional medicine. Clinical use of cannabinoid substances is restricted, due to legal and …

Background This review is one of a series on drugs used to treat chronic neuropathic pain.
Estimates of the population prevalence of chronic pain with neuropathic components range …

Cannabis‐based medicines are being approved for pain management in an increasing
number of European countries. There are uncertainties and controversies on the role and …

BACKGROUND: The management of chronic pain is a complex challenge worldwide.
Cannabis-based medicines (CBMs) have proven to be efficient in reducing chronic pain …

Background There has been increased interest in the role of cannabis for treating medical
conditions. The availability of different cannabis-based products can make the side effects of …

Objective: Debilitating pain, occurring in 50–70% of multiple sclerosis (MS) patients, is
poorly understood and infrequently studied. We summarized efficacy and safety data of …

Cannabinoids, cannabis, and cannabis-based medicines (CBM) are increasingly used to
manage pain, with limited understanding of their efficacy and safety. We assessed …

Cannabinoids, cannabis, and cannabis-based medicines (CBMs) are increasingly used to
manage pain, with limited understanding of their efficacy and safety. We summarised …

Neuropathic pain represents a broad category of pain syndromes that include a wide variety
of peripheral and central disorders. The overall prevalence of neuropathic pain in the …